Last reviewed · How we verify
Chemotherapy,checkpoint immunotherapy, targeted therapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Chemotherapy,checkpoint immunotherapy, targeted therapy (Chemotherapy,checkpoint immunotherapy, targeted therapy) — Shanghai Pudong Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chemotherapy,checkpoint immunotherapy, targeted therapy TARGET | Chemotherapy,checkpoint immunotherapy, targeted therapy | Shanghai Pudong Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chemotherapy,checkpoint immunotherapy, targeted therapy CI watch — RSS
- Chemotherapy,checkpoint immunotherapy, targeted therapy CI watch — Atom
- Chemotherapy,checkpoint immunotherapy, targeted therapy CI watch — JSON
- Chemotherapy,checkpoint immunotherapy, targeted therapy alone — RSS
Cite this brief
Drug Landscape (2026). Chemotherapy,checkpoint immunotherapy, targeted therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/chemotherapy-checkpoint-immunotherapy-targeted-therapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab